See more : Shires Income Plc (SHRS.L) Income Statement Analysis – Financial Results
Complete financial analysis of MediXall Group, Inc. (MDXL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MediXall Group, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Guoanda Co., Ltd. (300902.SZ) Income Statement Analysis – Financial Results
- Rouchon Industries, Inc. (RCHN) Income Statement Analysis – Financial Results
- Sinotrans Limited (601598.SS) Income Statement Analysis – Financial Results
- Eros Media World Plc (ESGC) Income Statement Analysis – Financial Results
- IMAGE MAGIC Inc. (7793.T) Income Statement Analysis – Financial Results
MediXall Group, Inc. (MDXL)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.medixall.com
About MediXall Group, Inc.
MediXall Group, Inc., together with its subsidiaries, develops and operates a healthcare marketplace platform to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors in the United States. The company offers Health Karma platform that provides medical and wellness services to individuals, employer groups, and third-party administrators. MediXall Group, Inc. was incorporated in 1998 and is based in Fort Lauderdale, Florida.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 59.27K | 15.00K | 0.00 | 2.69K | 1.86K | 22.23K | 0.00 | 0.00 | 0.00 | 42.50K | 0.00 |
Cost of Revenue | 3.20M | 3.07M | 2.53M | 1.37M | 1.71M | 836.63 | 192.16K | 109.87K | 0.00 | 0.00 | 0.00 |
Gross Profit | -3.14M | -3.05M | -2.53M | -1.37M | -1.71M | 21.40K | -192.16K | -109.87K | 0.00 | 42.50K | 0.00 |
Gross Profit Ratio | -5,296.21% | -20,349.52% | 0.00% | -51,065.21% | -92,010.17% | 96.24% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
Research & Development | 38.82K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.84M | 6.40M | 5.31M | 3.42M | 2.90M | 1.66M | 456.82K | 202.78K | 684.09K | 1.02M | 130.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 391.10K | 0.00 | 8.19 | 35.98 | 0.00 | 0.00 | 0.00 |
SG&A | 5.84M | 6.40M | 5.31M | 3.42M | 2.90M | 1.66M | 465.01K | 238.75K | 684.09K | 1.02M | 130.00K |
Other Expenses | 180.51K | -16.50K | 623.58K | 3.04M | -391.10K | 1.54B | 630.38K | 312.65K | 552.54K | 0.00 | 0.00 |
Operating Expenses | 59.27K | 6.38M | 5.93M | 3.42M | 2.90M | 1.66M | 465.01K | 238.75K | 684.09K | 1.02M | 130.00K |
Cost & Expenses | 6.60M | 6.38M | 5.93M | 3.42M | 2.90M | 1.66M | 657.16K | 348.62K | 684.09K | 1.02M | 130.00K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 271.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.13K | -20.00K |
Depreciation & Amortization | 35.72K | 4.00K | 4.00K | 4.00K | 3.15K | 3.00K | 657.16K | 348.62K | 0.00 | 0.00 | -40.00K |
EBITDA | -6.52M | -6.12M | -5.93M | -3.42M | -2.89M | -1.56M | 0.00 | 0.00 | -684.09K | -979.06K | -170.00K |
EBITDA Ratio | -11,006.92% | -43,534.59% | 0.00% | -124,804.66% | -151,073.41% | -7,367.13% | 0.00% | 0.00% | 0.00% | -2,303.67% | 0.00% |
Operating Income | -6.54M | -6.53M | -5.93M | -3.42M | -2.90K | -1.64M | -657.16K | -348.62K | -684.09K | -979.06K | -130.00K |
Operating Income Ratio | -11,035.15% | -43,561.27% | 0.00% | -127,409.72% | -155.91% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,303.67% | 0.00% |
Total Other Income/Expenses | -290.10K | 182.22K | -623.58K | 0.00 | -86.67K | 0.00 | 0.00 | 0.00 | 0.00 | -9.13K | -21.91K |
Income Before Tax | -6.83M | -6.20M | -5.93M | -3.42M | -2.98M | -1.64M | -657.16K | -348.62K | -684.09K | -988.19K | -150.00K |
Income Before Tax Ratio | -11,524.63% | -41,350.94% | 0.00% | -127,409.72% | -160,572.07% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,325.16% | 0.00% |
Income Tax Expense | 0.00 | -165.72K | -202.30K | -101.91K | -86.67K | 0.00 | -657.16K | -348.62K | 0.00 | 0.00 | 0.00 |
Net Income | -6.83M | -6.03M | -5.93M | -3.42M | -2.98M | -1.64M | -657.16K | -348.62K | -684.09K | -988.19K | -150.00K |
Net Income Ratio | -11,524.63% | -40,245.78% | 0.00% | -127,409.72% | -160,572.07% | -7,380.62% | 0.00% | 0.00% | 0.00% | -2,325.16% | 0.00% |
EPS | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | -0.03 | -0.25 | -0.14 | -0.27 | -0.43 | -0.06 |
EPS Diluted | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | -0.03 | -0.25 | -0.14 | -0.27 | -0.43 | -0.06 |
Weighted Avg Shares Out | 116.66M | 104.20M | 90.63M | 74.13M | 65.01M | 54.84M | 2.60M | 2.54M | 2.52M | 2.28M | 2.52M |
Weighted Avg Shares Out (Dil) | 116.66M | 104.20M | 90.63M | 74.13M | 65.01M | 54.84M | 2.60M | 2.54M | 2.52M | 2.28M | 2.52M |
Health Karma(R) Group Announces Partnership with OXIO Health, Inc. to offer access to Centralized Personal Health Record using Artificial Intelligence
Health Karma Group Announces a Strategic Partnership with RocketTools.io AI-Drive Creative Services
Health Karma Group Announces a Strategic Partnership with Wanido for Employee-Centric Companies
Health Karma(R) Group Selected by Invicta Benefits Group as the Provider of Virtual Health and Well-being Benefits
MediXall Group & Health Karma(R) CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th
Innovative Healthcare Solutions Provider 'Health Karma' Reports Many Accomplishments To Date This Year
MediXall Group Announces Appointment of Experienced Health Insurance Technology Executive Travis Jackson as New Chief Executive Officer of Health Karma
MediXall Group Hires Leading PR Firm, TransMedia Group, to Drive Brand Awareness & Media Relations to Propel Health Karma on Its Next Phase of Growth
MediXall Group Subsidiary Health Karma Mental Health Awareness Campaign Drives Consumer Acquisition
As Big Pharma Continues to Hike Prices, Health Karma, Subsidiary of MediXall Group, Reduces Cost of Prescription Medications
Source: https://incomestatements.info
Category: Stock Reports